Literature DB >> 19759226

Molecular and phenotypic characteristics of methicillin-resistant and vancomycin-intermediate staphylococcus aureus isolates from patients with septic arthritis.

Wei-Yao Wang1, Shih-Yi Lee, Tzong-Shi Chiueh, Jang-Jih Lu.   

Abstract

Staphylococcus aureus is one of the most common pathogens in community- and hospital-associated infections and frequently causes severe and intractable infections in osteoarticular tissues. S. aureus isolates that are resistant to methicillin (meticillin) (MRSA isolates) and intermediately resistant to vancomycin (VISA isolates) have emerged. In this report, we described two patients, one female and one male, diagnosed with septic arthritis due to S. aureus infections. A total of 13 MRSA isolates were obtained from these two patients. All but one isolate belonged to the VISA group. All seven isolates from the female patient were determined to be community associated, multilocus sequence type (MLST) 59, and staphylococcal cassette chromosome mecA (SCCmec) type IV; had direct repeat units (DRUs) of nine repeats; were spa type t437; and were susceptible to sulfa and quinolone antibiotics. The other six isolates, from the male patient, were determined to be hospital associated, MLST 239, and SCCmec type III; had DRUs of 14 repeats; were spa type t037; and were resistant to sulfa and quinolone antibiotics. All 13 MRSA isolates were in agr group I, were pvl negative, and showed no evidence of any association between vancomycin resistance and autolysis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19759226      PMCID: PMC2772649          DOI: 10.1128/JCM.00539-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  44 in total

1.  Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus.

Authors:  T Ito; Y Katayama; K Asada; N Mori; K Tsutsumimoto; C Tiensasitorn; K Hiramatsu
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

2.  Genetic variation among hospital isolates of methicillin-sensitive Staphylococcus aureus: evidence for horizontal transfer of virulence genes.

Authors:  P C Moore; J A Lindsay
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

3.  A simple infection model using pre-colonized implants to reproduce rat chronic Staphylococcus aureus osteomyelitis and study antibiotic treatment.

Authors:  M Monzón; F García-Alvarez; A Laclériga; E Gracia; J Leiva; C Oteiza; B Amorena
Journal:  J Orthop Res       Date:  2001-09       Impact factor: 3.494

4.  Methicillin resistant Staphylococcus aureus versus methicillin sensitive Staphylococcus aureus adult haematogenous septic arthritis.

Authors:  Shafic S Al-Nammari; Peter Bobak; Ramakrishnan Venkatesh
Journal:  Arch Orthop Trauma Surg       Date:  2007-01-27       Impact factor: 3.067

5.  Bacterial cell wall-expressed protein A triggers supraclonal B-cell responses upon in vivo infection with Staphylococcus aureus.

Authors:  Niklas Palmqvist; Gregg J Silverman; Elisabet Josefsson; Andrzej Tarkowski
Journal:  Microbes Infect       Date:  2005-07-01       Impact factor: 2.700

6.  Experience with linezolid therapy in children with osteoarticular infections.

Authors:  Chih-Jung Chen; Cheng-Hsun Chiu; Tzou-Yien Lin; Zhon-Liau Lee; Wen-E Yang; Yhu-Chering Huang
Journal:  Pediatr Infect Dis J       Date:  2007-11       Impact factor: 2.129

7.  Pediatric bone and joint infections caused by Panton-Valentine leukocidin-positive Staphylococcus aureus.

Authors:  Bruno Dohin; Yves Gillet; Rémi Kohler; Gérard Lina; François Vandenesch; Philippe Vanhems; Daniel Floret; Jerome Etienne
Journal:  Pediatr Infect Dis J       Date:  2007-11       Impact factor: 2.129

8.  Epidemic community-associated methicillin-resistant Staphylococcus aureus: recent clonal expansion and diversification.

Authors:  Adam D Kennedy; Michael Otto; Kevin R Braughton; Adeline R Whitney; Liang Chen; Barun Mathema; Jose R Mediavilla; Kelly A Byrne; Larye D Parkins; Fred C Tenover; Barry N Kreiswirth; James M Musser; Frank R DeLeo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-23       Impact factor: 11.205

9.  A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004-2005.

Authors:  Catherine Liu; Christopher J Graber; Michael Karr; Binh An Diep; Li Basuino; Brian S Schwartz; Mark C Enright; Simon J O'Hanlon; Jonathon C Thomas; Francoise Perdreau-Remington; Shelley Gordon; Helen Gunthorpe; Richard Jacobs; Peter Jensen; Gifford Leoung; James S Rumack; Henry F Chambers
Journal:  Clin Infect Dis       Date:  2008-06-01       Impact factor: 9.079

10.  Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus.

Authors:  M C Enright; N P Day; C E Davies; S J Peacock; B G Spratt
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

View more
  10 in total

1.  Clonal spreading of methicillin-resistant SCCmec Staphylococcus aureus with specific spa and dru types in central Taiwan.

Authors:  C-M Ho; M-W Ho; C-Y Lee; N Tien; J-J Lu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-26       Impact factor: 3.267

2.  Emergence of vancomycin-intermediate Staphylococcus aureus from predominant methicillin-resistant S. aureus clones in a Korean hospital.

Authors:  Hwa Yun Cha; Hyun Ok Kim; Jong Sook Jin; Je Chul Lee
Journal:  J Microbiol       Date:  2010-08-20       Impact factor: 3.422

3.  Molecular typing and phenotype characterization of methicillin-resistant Staphylococcus aureus isolates from blood in Taiwan.

Authors:  Wei-Yao Wang; Tzong-Shi Chiueh; Jun-Ren Sun; Shin-Ming Tsao; Jang-Jih Lu
Journal:  PLoS One       Date:  2012-01-23       Impact factor: 3.240

4.  Effects of Low-Level Laser Therapy, 660 nm, in Experimental Septic Arthritis.

Authors:  Bruna Formentão Araujo; Lígia Inez Silva; Anamaria Meireles; Camila Thieimi Rosa; Nereida Mello da Rosa Gioppo; Alex Sandro Jorge; Regina Inês Kunz; Lucinéia de Fátima Chasko Ribeiro; Rose Meire Costa Brancalhão; Gladson Ricardo Flor Bertolini
Journal:  ISRN Rheumatol       Date:  2013-08-12

5.  Bacteriological and molecular assessment of staphylococcal enterotoxin e in the blood of patients with rheumatoid arthritis.

Authors:  Samaneh Zahiri Yeganeh; Ramezan Ali Ataee; Gholam Hossein Alishiri; Monireh Movahedi
Journal:  Jundishapur J Microbiol       Date:  2015-02-18       Impact factor: 0.747

6.  Novel single-nucleotide variations associated with vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.

Authors:  Lee-Chung Lin; Shih-Cheng Chang; Mao-Cheng Ge; Tsui-Ping Liu; Jang-Jih Lu
Journal:  Infect Drug Resist       Date:  2018-01-18       Impact factor: 4.003

7.  Application of a MALDI-TOF analysis platform (ClinProTools) for rapid and preliminary report of MRSA sequence types in Taiwan.

Authors:  Hsin-Yao Wang; Frank Lien; Tsui-Ping Liu; Chun-Hsien Chen; Chao-Jung Chen; Jang-Jih Lu
Journal:  PeerJ       Date:  2018-11-07       Impact factor: 2.984

8.  Genetic Characterization of Methicillin Resistant and Sensitive, Vancomycin Intermediate Staphylococcus aureus Strains Isolated from Different Iranian Hospitals.

Authors:  Seyed Asghar Havaei; Amir Azimian; Hosein Fazeli; Mahmood Naderi; Kiarash Ghazvini; Siamak Mirab Samiee; Zahra Masoumi; Mojtaba Akbari
Journal:  ISRN Microbiol       Date:  2012-12-20

Review 9.  Systematic Review and Meta-Analysis of the Epidemiology of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates.

Authors:  Shanshan Zhang; Xiaoxi Sun; Wenjiao Chang; Yuanyuan Dai; Xiaoling Ma
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

10.  Clinical outcomes and molecular typing of heterogenous vancomycin-intermediate Staphylococcus aureus bacteremia in patients in intensive care units.

Authors:  Han-Chung Hu; Kuo-Chin Kao; Li-Chung Chiu; Chih-Hao Chang; Chen-Yiu Hung; Li-Fu Li; Tsui-Ping Liu; Lee-Chung Lin; Ning-Hung Chen; Chung-Chi Huang; Cheng-Ta Yang; Jang-Jih Lu
Journal:  BMC Infect Dis       Date:  2015-10-23       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.